Probing the Active Site of Monoamine Oxidase B: Using Simulation to Understand Parkinson's Disease

被引：0
|
作者：
Allen, William Joseph [1 ]
Bevan, David R. [1 ]
机构：
[1] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2008年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [1] Monoamine Oxidase B Inhibitors in Parkinson's Disease
    Dezsi, Livia
    Vecsei, Lzszlo
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 425 - 439
  • [2] Mitochondria, monoamine oxidase B and Parkinson's disease
    Jenner, Peter
    [J]. BASAL GANGLIA, 2012, 2 (04) : S3 - S7
  • [3] Monoamine oxidase B gene polymorphism and Parkinson's disease
    Sazci, A.
    Akpinar, G.
    Idrisoglu, H. A.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S244 - S244
  • [4] A polymorphism of monoamine oxidase B and the risk of Parkinson's disease.
    Hernán, MA
    Checkoway, H
    Liu, M
    Costa-Mallen, P
    Kelsey, KT
    Ascherio, A
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S54 - S54
  • [5] Platelet monoamine oxidase B and plasma β-phenylethylamine in Parkinson's disease
    Zhou, G
    Miura, Y
    Shoji, H
    Yamada, S
    Matsuishi, T
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (02): : 229 - 231
  • [6] Monoamine oxidase-B inhibition in the treatment of Parkinson's disease
    Fernandez, Hubert H.
    Chen, Jack J.
    [J]. PHARMACOTHERAPY, 2007, 27 (12): : 174S - 185S
  • [7] Pharmacokinetics of monoamine oxidase B inhibitors in Parkinson's disease: current status
    Mueller, Thomas
    Moehr, Jan-Dominique
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 429 - 435
  • [8] Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
    Daphne Robakis
    Stanley Fahn
    [J]. CNS Drugs, 2015, 29 : 433 - 441
  • [9] Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease
    Mellick, GD
    Buchanan, DD
    McCann, SJ
    James, KM
    Johnson, AG
    Davis, DR
    Liyou, N
    Chan, D
    Le Couteur, DG
    [J]. MOVEMENT DISORDERS, 1999, 14 (02) : 219 - 224
  • [10] Controversies in type B monoamine oxidase inhibitor treatment of Parkinson's disease
    Yamamoto, M
    [J]. JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1997, 19 (07): : 671 - 683
12345